NASDAQ : BIAF
bioAffinity Technologies, Inc. — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 3.03 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
bioAffinity Technologies, Inc. (BIAF) reported revenue of 5.90M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 5.90M | 6.16M | 9.36M | 2.53M | 4.80K | |
| Cost of Revenue | 3.86M | 4.23M | 5.98M | 1.74M | 467.00 | |
| Gross Profit | 2.04M | 1.94M | 3.38M | 791.62K | 4.34K | |
| Selling, General & Admin | 11.35M | 9.91M | 9.94M | 6.79M | 2.48M | 1.07M |
| Research & Development | 2.66M | 2.09M | 1.78M | 1.72M | 1.52M | 1.14M |
| Operating Expenses | 14.42M | 12.51M | 12.33M | 8.76M | 4.02M | 2.21M |
| Operating Income | -12.38M | -10.57M | -8.95M | -7.97M | -4.01M | -2.21M |
| Interest Expense | -44.84K | -44.37K | -92.47K | -37.12K | -2.53M | -1.00M |
| Interest & Investment Income | 34.20K | 23.39K | 17.61K | 122.13K | 46.71K | 424.00 |
| Other Non Operating Income (Expenses) | -2.79M | -4.27M | 129.00 | -27.80K | -1.87M | -3.36M |
| EBT Excluding Unusual Items | -15.18M | -14.87M | -9.03M | -7.92M | -8.36M | -6.56M |
| Other Unusual Items | 212.26K | 239.20K | ||||
| Pretax Income | -15.18M | -14.87M | -9.03M | -7.92M | -8.15M | -6.32M |
| Income Tax Expense | 6.36K | 44.04K | 11.65K | 20.99K | 2.46K | 1.95K |
| Net Income | -15.19M | -14.91M | -9.04M | -7.94M | -8.15M | -6.33M |
| Net Income to Common | -15.19M | -14.91M | -9.04M | -7.94M | -8.15M | -6.33M |
| Shares Outstanding (Basic) | 254.38K | 114.74K | 26.94K | 19.44K | ||
| Shares Outstanding (Diluted) | 254.38K | 114.74K | 26.94K | 19.44K | ||
| EPS (Basic) | -59.70 | -129.94 | -335.50 | -408.30 | ||
| EPS (Diluted) | -59.70 | -129.94 | -335.50 | -408.30 | ||
| Free Cash Flow | -11.56M | -9.39M | -7.34M | -6.06M | -4.29M | -2.05M |
| Free Cash Flow Per Share | -45.45 | -81.83 | -272.56 | -311.78 | ||
| Gross Margin | 34.61% | 31.41% | 36.09% | 31.26% | 90.28% | |
| Operating Margin | -209.82% | -171.58% | -95.64% | -314.84% | -83,511.51% | |
| Profit Margin | -257.33% | -241.96% | -96.56% | -313.41% | -169,771.25% | |
| Free Cash Flow Margin | -195.90% | -152.38% | -78.44% | -239.32% | -89,336.50% | |
| EBITDA | -11.97M | -10.07M | -8.35M | -7.72M | -4.00M | -2.20M |
| EBITDA Margin | -202.82% | -163.38% | -89.17% | |||
| D&A For EBITDA | 413.09K | 504.84K | 605.64K | 249.59K | 10.18K | 4.82K |
| EBIT | -12.38M | -10.57M | -8.95M | -7.97M | -4.01M | -2.21M |
| EBIT Margin | -209.82% | -171.58% | -95.64% | |||
| Advertising Expenses | 340.00K | 267.00K | 88.83K | 39.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.43M | 6.45M | 1.11M | 2.82M | 11.41M | 1.36M |
| Cash & Short-Term Investments | 2.43M | 6.45M | 1.11M | 2.82M | 11.41M | 1.36M |
| Accounts Receivable | 875.52K | 515.67K | 1.11M | 782.12K | 1.53K | |
| Other Receivables | 19.30K | 26.30K | 27.87K | 29.55K | 10.49K | |
| Receivables | 894.82K | 541.96K | 1.14M | 811.67K | 10.49K | 1.53K |
| Inventory | 82.38K | 53.55K | 27.61K | 18.48K | 5.54K | |
| Prepaid Expenses | 137.15K | 227.95K | 248.36K | 171.85K | 340.08K | 16.77K |
| Other Current Assets | 321.21K | 291.97K | 174.63K | 149.16K | 191.82K | 59.30K |
| Total Current Assets | 3.87M | 7.57M | 2.70M | 3.97M | 11.96M | 1.44M |
| Property, Plant & Equipment | 1.65M | 1.26M | 1.62M | 1.99M | 214.44K | 4.63K |
| Goodwill | 1.40M | 1.40M | 1.40M | 1.40M | ||
| Other Intangible Assets | 687.64K | 716.81K | 775.14K | 833.47K | ||
| Long-Term Deferred Charges | 7.94K | |||||
| Other Long-Term Assets | 16.71K | 12.81K | 19.68K | 16.06K | 6.00K | 2.50K |
| Total Assets | 7.62M | 10.96M | 6.51M | 8.22M | 12.18M | 1.45M |
| Accounts Payable | 969.85K | 761.90K | 987.31K | 604.79K | 345.04K | 230.41K |
| Accrued Expenses | 1.41M | 1.72M | 1.40M | 1.15M | 541.89K | 1.60M |
| Short-Term Debt | 251.75K | 11.15M | ||||
| Current Portion of Long-Term Debt | 22.56K | 105.16K | 171.67K | 52.07K | ||
| Current Portion of Leases | 242.87K | 278.71K | 522.80K | 460.17K | ||
| Current Unearned Revenue | 31.14K | 42.41K | 24.40K | 33.06K | ||
| Total Current Liabilities | 2.68M | 2.91M | 3.10M | 2.25M | 1.14M | 13.04M |
| Long-Term Debt | 36.47K | 41.31K | 20.18K | 160.18K | ||
| Long-Term Leases | 1.13M | 735.64K | 786.55K | 1.12M | ||
| Total Liabilities | 3.85M | 3.68M | 3.91M | 3.37M | 1.14M | 13.20M |
| Common Stock | 47.45K | 31.46K | 3.55K | 65.76K | 58.67K | 18.74K |
| Additional Paid-In Capital | 79.27M | 75.80M | 56.24M | 49.39M | 47.65M | 12.70M |
| Retained Earnings | -75.55M | -68.55M | -53.64M | -44.60M | -36.67M | -28.51M |
| Total Common Equity | 3.77M | 7.28M | 2.60M | 4.86M | 11.04M | -15.79M |
| Shareholders' Equity | 3.77M | 7.28M | 2.60M | 4.86M | 11.04M | -11.75M |
| Total Liabilities & Equity | 7.62M | 10.96M | 6.51M | 8.22M | 12.18M | 1.45M |
| Total Debt | 1.44M | 1.16M | 1.50M | 1.58M | 251.75K | 11.36M |
| Net Cash (Debt) | 994.71K | 5.29M | -395.90K | 1.24M | 11.16M | -10.00M |
| Net Cash Per Share | 3.91 | 46.10 | -14.69 | 63.94 | ||
| Filing Date Shares Outstanding | 539.86K | 299.62K | 39.61K | 25.59K | 18.81K | |
| Total Common Shares Outstanding | 451.95K | 299.62K | 33.84K | 20.88K | 18.62K | |
| Working Capital | 1.18M | 4.66M | -409.81K | 1.72M | 10.82M | -11.60M |
| Book Value Per Share | 8.34 | 24.29 | 76.89 | 232.56 | 592.94 | |
| Tangible Book Value | 1.68M | 5.16M | 422.41K | 2.62M | 11.04M | -15.79M |
| Tangible Book Value Per Share | 3.71 | 17.21 | 12.48 | 125.37 | 592.94 | |
| Machinery | 912.60K | 937.06K | 892.28K | 821.82K | 483.62K | 263.63K |
| Leasehold Improvements | 104.39K | 32.78K | 19.35K | 9.94K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -15.19M | -14.91M | -9.04M | -7.94M | -8.15M | -6.33M |
| Depreciation & Amortization | 413.09K | 504.84K | 605.64K | 249.59K | 10.18K | 4.82K |
| Other Amortization | 2.06M | 480.57K | ||||
| Loss (Gain) From Sale of Investments | 2.75M | 3.81M | ||||
| Stock-Based Compensation | 932.53K | 671.47K | 989.68K | 748.82K | 248.59K | 43.01K |
| Other Operating Activities | 1.65M | 3.12M | ||||
| Change in Accounts Receivable | -472.95K | 597.24K | -327.53K | 311.37K | -8.96K | |
| Change in Inventory | -38.41K | -25.94K | -9.12K | -12.94K | -5.54K | |
| Change in Accounts Payable | -199.99K | -225.41K | 382.52K | -14.50K | 114.64K | 39.02K |
| Change in Unearned Revenue | 6.74K | 18.00K | -8.65K | 33.06K | ||
| Change in Other Net Operating Assets | 328.57K | 230.43K | 142.50K | 583.81K | 14.07K | 593.80K |
| Operating Cash Flow | -11.47M | -9.33M | -7.26M | -6.04M | -4.07M | -2.05M |
| Capital Expenditures | -91.99K | -60.57K | -79.08K | -22.90K | -219.99K | |
| Cash Acquisitions | -2.19M | |||||
| Investing Cash Flow | -91.99K | -60.57K | -79.08K | -2.21M | -219.99K | |
| Short-Term Debt Issued | 724.00K | 3.29M | ||||
| Long-Term Debt Issued | 191.85K | 555.15K | 212.26K | |||
| Total Debt Issued | 191.85K | 1.28M | 3.51M | |||
| Long-Term Debt Repaid | -369.72K | -361.18K | -344.98K | -694.98K | ||
| Net Debt Issued (Repaid) | -248.17K | -369.72K | -169.33K | -344.98K | 584.16K | 3.51M |
| Issuance of Common Stock | 14.22M | 15.89M | 7.06M | 13.82M | ||
| Repurchase of Common Stock | -185.00 | |||||
| Other Financing Activities | -1.77M | -1.77M | -1.26M | -55.65K | -180.75K | |
| Financing Cash Flow | 13.19M | 14.73M | 5.63M | -344.98K | 14.34M | 3.33M |
| Net Cash Flow | 1.63M | 5.34M | -1.72M | -8.59M | 10.05M | 1.28M |
| Free Cash Flow | -11.56M | -9.39M | -7.34M | -6.06M | -4.29M | -2.05M |
| Free Cash Flow Margin | -195.90% | -152.38% | -78.44% | -239.32% | -89,336.50% | |
| Free Cash Flow Per Share | -45.45 | -81.83 | -272.56 | -311.78 | ||
| Levered Free Cash Flow | -6.91M | -4.93M | -3.95M | -3.73M | -3.41M | -851.26K |
| Unlevered Free Cash Flow | -6.88M | -4.91M | -3.90M | -3.71M | -3.89M | -705.67K |
| Cash Interest Paid | 34.20K | 23.39K | 17.61K | 37.12K | 30.64K | |
| Cash Income Tax Paid | 6.36K | 44.04K | 11.65K | 20.99K | 2.46K | 1.95K |
| Change in Working Capital | -376.05K | 594.32K | 179.72K | 900.79K | 114.20K | 632.82K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.73M | 5.30M | 14.18M | 13.97M | 13.39M | |
| Enterprise Value | 2.74M | -1.69M | 15.14M | 11.15M | 708.47K | |
| Last Close Price | 2.91 | 17.70 | 409.50 | 661.73 | 720.00 | |
| PS Ratio | 0.63 | 0.86 | 1.51 | 5.52 | 2,788.11 | |
| PB Ratio | 0.35 | 0.73 | 5.45 | 2.88 | 1.21 | |
| P/TBV Ratio | 2.23 | 1.03 | 33.57 | 5.34 | 1.21 | |
| EV/Sales Ratio | 0.46 | 1.62 | 4.40 | 147.50 | ||
| Debt / Equity Ratio | 0.38 | 0.16 | 0.58 | 0.33 | 0.02 | -0.97 |
| Net Debt / Equity Ratio | -0.26 | -0.73 | 0.15 | -0.26 | -1.01 | -0.85 |
| Net Debt / EBITDA Ratio | 0.08 | 0.53 | -0.05 | 0.16 | 2.79 | -4.54 |
| Net Debt / FCF Ratio | 0.09 | 0.56 | -0.05 | 0.20 | 2.60 | -4.88 |
| Asset Turnover | 0.95 | 0.70 | 1.27 | 0.25 | 0.00 | |
| Inventory Turnover | 61.08 | 104.17 | 259.63 | 144.93 | ||
| Quick Ratio | 1.24 | 2.41 | 0.72 | 1.62 | 10.03 | 0.10 |
| Current Ratio | 1.44 | 2.60 | 0.87 | 1.77 | 10.51 | 0.11 |
| Return on Equity (ROE) | -1,860.15% | -301.83% | -242.44% | -99.84% | ||
| Return on Assets (ROA) | -125.11% | -75.63% | -75.95% | -48.85% | -36.77% | -172.53% |
| Return on Capital Employed (ROCE) | -250.70% | -131.30% | -262.70% | -133.50% | -36.30% | 19.00% |
| Earnings Yield | -2,051.38% | -281.29% | -63.74% | -56.80% | -60.89% | |
| FCF Yield | -309.65% | -177.14% | -51.78% | -43.37% | -32.04% | |
| Buyback Yield / Dilution | -578.55% | -325.84% | -38.61% |